Home › Stocks › MD › All Fund Holders
MD — PEDIATRIX MEDICAL GROUP INC · All Fund Holders
Funds holding (latest): 45 · Reported value held: $1.03B
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 13.71M | $347.38M | 0.01% | Add |
| Vanguard Group history | Q4 2025 | 10.72M | $229.39M | 0.00% | Reduce |
| Geode Capital Management history | Q2 2026 | 2.23M | $56.40M | 0.00% | Add |
| D. E. Shaw & Co history | Q2 2026 | 1.61M | $40.86M | 0.02% | Reduce |
| Morgan Stanley history | Q2 2026 | 1.33M | $33.65M | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 1.29M | $32.78M | 0.00% | Reduce |
| Renaissance Technologies history | Q2 2026 | 1.29M | $32.61M | 0.04% | Reduce |
| Invesco Ltd history | Q2 2026 | 1.17M | $29.73M | 0.00% | Add |
| PSP Investments history | Q2 2026 | 987.86K | $25.02M | 0.07% | Add |
| Northern Trust Corp history | Q2 2026 | 934.31K | $23.67M | 0.00% | Add |
| Royce & Associates history | Q2 2026 | 914.35K | $23.16M | 0.19% | Add |
| Goldman Sachs Group history | Q2 2026 | 825.64K | $20.91M | 0.01% | Reduce |
| Fidelity Management & Research (FMR) history | Q2 2026 | 741.39K | $18.78M | 0.00% | Reduce |
| BNY Mellon history | Q2 2026 | 564.42K | $14.30M | 0.00% | Reduce |
| Principal Global Investors history | Q2 2026 | 461.33K | $11.69M | 0.01% | Reduce |
| AQR Capital Management history | Q2 2026 | 471.29K | $11.53M | 0.00% | Reduce |
| UBS Group AG history | Q2 2026 | 435.82K | $11.04M | 0.00% | Add |
| Franklin Resources history | Q2 2026 | 421.26K | $10.67M | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 309.41K | $7.84M | 0.00% | Reduce |
| Prudential Financial history | Q2 2026 | 283.69K | $7.19M | 0.01% | Reduce |
| JPMorgan Chase & Co history | Q2 2026 | 209.89K | $5.27M | 0.00% | New |
| Legal & General Investment Management America history | Q2 2026 | 183.10K | $4.64M | 0.00% | Reduce |
| Lazard Asset Management history | Q2 2026 | 179.78K | $4.55M | 0.01% | Add |
| Norges Bank Investment Management history | Q2 2024 | 560.26K | $4.23M | 0.00% | Reduce |
| Arrowstreet Capital history | Q4 2025 | 192.53K | $4.12M | 0.00% | Add |
| Wells Fargo & Co history | Q2 2026 | 86.46K | $2.19M | 0.00% | Add |
| Deutsche Bank AG history | Q2 2026 | 86.42K | $2.19M | 0.00% | Add |
| Citigroup Inc history | Q2 2026 | 73.04K | $1.85M | 0.00% | Add |
| Citadel Advisors history | Q1 2026 | 73.00K | $1.56M | 0.00% | Reduce |
| Millennium Management history | Q2 2026 | 55.12K | $1.40M | 0.00% | New |
| Two Sigma Investments history | Q2 2026 | 45.47K | $1.15M | 0.00% | Reduce |
| Point72 Asset Management history | Q3 2025 | 67.77K | $1.14M | 0.00% | Reduce |
| Manulife Financial history | Q2 2026 | 40.68K | $1.03M | 0.00% | Add |
| Marshall Wace history | Q2 2026 | 34.43K | $872.06K | 0.00% | New |
| Janus Henderson Group history | Q1 2026 | 34.26K | $732.74K | 0.00% | Hold |
| Moore Capital Management history | Q3 2025 | 40.40K | $676.70K | 0.01% | New |
| Wellington Management Group history | Q1 2023 | 44.16K | $658.47K | 0.00% | New |
| Amundi US history | Q2 2026 | 23.86K | $604.48K | 0.00% | Add |
| Maverick Capital history | Q1 2023 | 32.69K | $487.38K | 0.01% | New |
| Bridgewater Associates history | Q3 2024 | 32.88K | $381.09K | 0.00% | Reduce |
| PNC Financial Services history | Q2 2026 | 11.03K | $279.34K | 0.00% | Reduce |
| Balyasny Asset Management history | Q1 2026 | 10.86K | $232.29K | 0.00% | New |
| CPP Investments history | Q4 2025 | 8.80K | $188.23K | 0.00% | Add |
| BROWN BROTHERS HARRIMAN & CO history | Q2 2026 | 372 | $9.42K | 0.00% | New |
| T. Rowe Price Associates history | Q2 2026 | 112.02K | $2.84K | 0.00% | Add |